Metabolix (YTEN)
(Delayed Data from NSDQ)
$6.04 USD
+0.17 (2.90%)
Updated May 10, 2024 03:59 PM ET
After-Market: $6.07 +0.03 (0.50%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Metabolix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 1 | 1 | 1 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 1 | 1 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 14 | 14 | 12 | 10 | 9 |
Income After Depreciation & Amortization | -14 | -13 | -12 | -10 | -9 |
Non-Operating Income | 0 | 0 | 1 | -1 | -5 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -14 | -13 | -11 | -10 | -13 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -14 | -14 | -11 | -10 | -13 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -14 | -14 | -11 | -10 | -13 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -14 | -13 | -11 | -9 | -8 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 0 | 0 | 0 |
Income After Depreciation & Amortization | -14 | -13 | -12 | -10 | -9 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 0.33 | 0.21 | 0.20 | 0.10 | 0.02 |
Diluted EPS Before Non-Recurring Items | -43.65 | -66.19 | -55.88 | -103.12 | -851.32 |
Diluted Net EPS (GAAP) | -1.82 | -2.76 | -2.33 | -4.30 | -35.50 |
Fiscal Year end for Metabolix, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 0.00 | 0.00 | 0.00 | 0.06 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 0.00 | 0.00 | 0.00 | 0.06 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 3.25 | 3.70 | 3.67 | 3.86 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -3.25 | -3.70 | -3.67 | -3.80 |
Non-Operating Income | NA | -0.02 | -0.02 | -0.01 | 0.02 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -3.27 | -3.73 | -3.68 | -3.78 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -3.27 | -3.73 | -3.68 | -3.78 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -3.27 | -3.73 | -3.68 | -3.78 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 0.50 | 0.38 | 0.24 | 0.21 |
Diluted EPS Before Non-Recurring Items | NA | -6.47 | -9.83 | -15.35 | -18.23 |
Diluted Net EPS (GAAP) | NA | -0.01 | -0.41 | -0.64 | -0.76 |